title: What, how, and how much should patients with burns be fed?
abstract: The hypermetabolic response to severe burn injury is characterized by hyperdynamic circulation and profound metabolic, physiologic, catabolic, and immune system derangements. Failure to satisfy overwhelming energy and protein requirements after, and during, severe burn injury results in multiorgan dysfunction, increased susceptibility to infection, and death. Attenuation of the hypermetabolic response by various pharmacologic modalities is emerging as an essential component of the management of patients with severe burn injury. This review focuses on the more recent advances in therapeutic strategies to attenuate the hypermetabolic response and its postburn-associated insulin resistance.
authors.affiliation: Department of Surgery, Shriners Hospital for Children and University of Texas Medical Branch, 815 Market Street, Galveston, TX 77550, USA.
authors.forename: Felicia N
authors.initials: FN
authors.lastname: Williams
authors.forename: Ludwik K
authors.initials: LK
authors.lastname: Branski
authors.forename: Marc G
authors.initials: MG
authors.lastname: Jeschke
authors.forename: David N
authors.initials: DN
authors.lastname: Herndon
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002056:Burns / Q000378:metabolism* / Q000628:therapy*; D002395:Catecholamines / Q000378:metabolism; D004750:Enteral Nutrition; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D008066:Lipolysis; D008099:Liver / Q000378:metabolism; D008687:Metformin / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism; D018529:Nutritional Support; D010289:Parenteral Nutrition, Total; D014945:Wound Healing / Q000502:physiology
chemical_list: D001786:Blood Glucose; D002395:Catecholamines; D007004:Hypoglycemic Agents; D008687:Metformin